LYC-30937-EC

DRUG3 trials

Sponsors

Lycera Corp.

Conditions

Colitis, UlcerativeUlcerative Colitis

Phase 2

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis

CompletedNCT02762500

Lycera Corp.Colitis, Ulcerative

Start: 2016-07-31End: 2018-05-31Updated: 2019-04-02

Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis

TerminatedNCT02764229

Lycera Corp.Colitis, Ulcerative

Start: 2016-11-01End: 2018-07-18Updated: 2019-03-27

A MULTICENTER OPEN-LABEL EXTENSION STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF LYC-30937-EC IN SUBJECTS WITH ACTIVE ULCERATIVE COLITIS

Active, not recruitingNL-OMON42876

Lycera Corp.Ulcerative Colitis

Start: 2017-04-19Target: 5Updated: 2024-02-28